Accreditation: 5.00 Nursing Contact Hours | 5.00 ABIM MOC II | 5.00 AMA PRA Category 1 Credit™ | 5.00 ACPE Pharmacy
Venue: Hyatt Regency Miami, 400 Southeast 2nd Street, Miami, FL, 33131, United States
Official conference page for 2026 Miami GU Oncology Summit. https://binaytara.org/projects/conferences/2026-miami-gu-oncology-summit
Saturday, November 14th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Rohan Garje, MD; Michael Carducci, MD
08:30 AM - 08:45 AM
The case for upfront PSMA radioligand therapy: Should Pluvicto become the first-line standard for all PSMA-positive prostate cancer? – Jordan Alana Ciuro, MD
08:45 AM - 09:00 AM
The case for chemotherapy intensification: When is ADT + ARPI + docetaxel the preferred first-line triplet in mAPMN/S prostate cancer? – Janaki Sharma, MD
09:00 AM - 09:15 AM
Case Presentation: Upfront PARP inhibition in mAPMN/S prostate cancer: Is BRCA2 the defining biomarker, and who benefits beyond it? – Umang Swami, MD
09:15 AM - 09:30 AM
Case Presentation: Capivasertib + abiraterone + ADT in PTEN-deficient mAPMN/S prostate cancer: Defining the ideal candidate? – Jingsong Zhang, MD, PhD
09:30 AM - 09:50 AM
Case-Based Panel Discussion
Moderators:
Rohan Garje, MD; Michael Carducci, MD
Panelists:
Vinay Minocha, MD
Session Chair: Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
09:50 AM - 10:05 AM
Case Presentation: The localized renal mass: Surgery, ablation, radiation, or surveillance?
10:05 AM - 10:20 AM
Case Presentation: Adjuvant therapy after nephrectomy: Who should we treat and with what? – Ulka Vaishampayan, MD
10:20 AM - 10:35 AM
Case Presentation: Metastatic disease: Choosing first-line therapy in clear-cell non–clear-cell – Tianshi Liu, MD
10:35 AM - 10:50 AM
Case Presentation: Non–clear-cell RCC: Histology, molecular drivers, and treatment selection – Rafael Arteta-Bulos, MD
10:50 AM - 11:10 AM
Case-Based Panel Discussion
Moderators:
Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
Panelists:
Raju Vaddepally, MD
Session Chair: Arnab Basu, MBBS, MPH; Manuel Ozambela, MD
11:25 AM - 11:40 AM
Case Presentation: Updates in the management of NMIBC – Indraneel Banerjee, MD, MBBS
11:40 AM - 11:55 AM
Case Presentation: Perioperative systemic therapy for MIBC — a moving target – Rohit Jain, MD
11:55 AM - 12:10 PM
Case Presentation: Front line treatment of metastatic urothelial carcinoma
12:10 PM - 12:25 PM
Case Presentation: Treatment options after EVP – Spencer Henick Bachow, MD
12:25 PM - 12:45 PM
Case-Based Panel Discussion
Moderators:
Arnab Basu, MBBS, MPH; Manuel Ozambela, MD
Panelists:
Jan Krzysztof Rudzinski, MD
Session Chair: Alena Karotkina, APRN; Kristine Landrian, DO
01:30 PM - 01:45 PM
Case Presentation: Symptom management – Kristine Landrian, DO
01:45 PM - 02:00 PM
Case presentation: Drug interaction – Isabel Houlzet, PharmD
02:00 PM - 02:15 PM
Case Presentation: Role of research coordinator in clinical trials – Leslie V Castaneda, MPH
02:15 PM - 02:35 PM
Case-Based Panel Discussion
Moderators:
Kristine Landrian, DO; Alena Karotkina, APRN
